...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma

【24h】

Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma

机译：复发性霍奇金淋巴瘤和非霍奇金淋巴瘤抢救治疗和自体造血细胞移植的时机

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共2页
作者
Lamar Zanetta S.; Fino Nora; Hurd David; Howard Dianna; McIver Zachariah A.; Phillips Gordon L.; Vaidya Rakhee;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma [J] . Lamar Zanetta S., Fino Nora, Hurd David, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：复发性霍奇金淋巴瘤和非霍奇金淋巴瘤抢救治疗和自体造血细胞移植的时机
2. Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. [J] . van Kampen RJ, Canals C, Schouten HC, Journal of Clinical Oncology . 2011,第10期

机译：自体干细胞移植后同种异体干细胞移植作为弥漫性大B细胞非霍奇金淋巴瘤复发的抢救疗法：欧洲血液和骨髓移植注册组织分析。
3. Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma [J] . Damlaj Moussab, Abuelgasim Khadega A., Alhejazi Ayman, Bone marrow transplantation . 2020,第12期

机译：Brentuximab Vedotin含盐蛋白，然后固结后自体造血干细胞移植在高风险中复发耐火古典霍奇金淋巴瘤
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. Long-Term Bone Mineral Density Loss Following Autologous and Allogeneic Hematopoietic Cell Transplantation and Effectiveness of Bone Loss Therapies to Combat the Loss. [D] . Croudy, Christopher M. 2012

机译：自体和同种异体造血细胞移植后的长期骨矿物质密度损失以及抗击骨损失疗法的有效性。
6. Long-Term Survival And Late Relapse In 2-Year Survivors Of Autologous Hematopoietic Cell Transplantation For Hodgkin And Non-Hodgkin Lymphoma [O] . Navneet S. Majhail, Ruta Bajorunaite, Hillard M. Lazarus, -1

机译：霍奇金与非霍奇金淋巴瘤自体造血细胞移植2年幸存者的长期存活和晚期复发
7. Patterns of Relapse after Salvage Autologous Hematopoietic Cell Transplantation for Hodgkin’s Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peritransplant Radiation Therapy [O] . J.C. Farris, A. Ritter, M.D. Craig, 2018

机译：抢救后复发后复制造血细胞移植治疗霍奇金淋巴瘤：应该使用相对于初始涉及的网站的复发遗址来指导亚过普拉斯植物放射治疗的适应症

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号